Literature DB >> 24841106

Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea.

Trygve Sørdahl Hall1, Tobias Erik Herrscher2, Petr Jarolim3, Morten Wang Fagerland4, Torstein Jensen5, Stefan Agewall6, Dan Atar6, Jonas Hallén7.   

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) and obesity are often present concomitantly. Their potential contribution to inflammation remains an ongoing debate. The objectives of this study were to investigate whether variables of sleep-disordered breathing are associated with levels of myeloid-related protein-8/14 (MRP-8/14) or C-reactive protein (CRP), and to characterize how adiposity interacts with these associations in individuals evaluated for possible OSA.
METHODS: Consecutive individuals referred to Lovisenberg Diakonale Hospital's sleep laboratory between 1st October 2009 and 1st March 2010 were included. We characterized the biomarker distribution sampled the morning after sleep and related these to clinical characteristics and variables recorded during polygraphy or polysomnography.
RESULTS: Of the total study population of 222 individuals, 161 (72.5%) were diagnosed with OSA (apnea-hypopnea index (AHI) > or = 5/h). In baseline models (multiple median regression adjusted for age and sex), AHI was independently associated with MRP-8/14 (P=0.025) and CRP (P<0.001). The associations were attenuated after the addition of body mass index (BMI), but remained statistically significant for CRP (P=0.025). However, in final models adjusted for additional factors (systolic blood pressure, cholesterol:high-density lipoprotein ratio, glycosylated haemoglobin, smoking, and cardiovascular disease), only average oxygen saturation for MRP-8/14 (P=0.028) and oxygen desaturation index (ODI) for CRP (P=0.037) remained independent predictors of inflammation, whereas AHI lost its predictive value (MRP-8/14; P=0.30 and CRP; P=0.092). The association between several variables of sleep-disordered breathing and inflammation were stronger in individuals with a higher BMI (P for interaction <0.05 for AHI, nadir oxygen saturation, and time <90% oxygen saturation).
CONCLUSIONS: No definitive indication of independent immunological activity resulting from apneas and hypopneas was found in final models adjusted for other factors associated with inflammation, whereas average oxygen saturation for MRP-8/14 and ODI for CRP remained statistically significant predictors. Interactions were observed between BMI and several variables of sleep-disordered breathing on MRP-8/14 and CRP levels.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Body mass index; C-reactive protein; Inflammation; Myeloid-related protein-8/14; Obstructive sleep apnea; Sleep-disordered breathing

Mesh:

Substances:

Year:  2014        PMID: 24841106     DOI: 10.1016/j.sleep.2014.03.008

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  4 in total

1.  Red cell distribution width: a new tool for the severity prediction of sleep apnoea syndrome in children.

Authors:  Daniel Morell-Garcia; Núria Toledo-Pons; Pilar Sanchis; Josep Miquel Bauça; José María Sánchez; José Peña-Zarza; Paloma Giménez; Javier Pierola; Mónica de la Peña-Bravo; Alberto Alonso-Fernández; Antònia Barceló
Journal:  ERJ Open Res       Date:  2020-10-05

2.  Targeting Sleep Disordered Breathing to Prevent Heart Failure: What is the Evidence?

Authors:  Kenya Kusunose; Reena Mehra
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-10-01

3.  The correlation of serum growth differentiation factor-15 level in patients with obstructive sleep apnea.

Authors:  Kamran Sari; Huseyin Ede; Zeliha Kapusuz Gencer; Mahmut Ozkiris; Ayse Yesim Gocmen; Yavuz Selim Intepe
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

Review 4.  Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Authors:  Konstantinos Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2014-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.